Suppr超能文献

相似文献

1
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.
Adv Drug Deliv Rev. 2012 Oct;64(13):1363-84. doi: 10.1016/j.addr.2012.08.005. Epub 2012 Aug 17.
2
Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
Biomater Sci. 2019 Oct 1;7(10):4000-4016. doi: 10.1039/c9bm00931k. Epub 2019 Jul 29.
3
Challenges in the development of nanoparticle-based imaging agents: Characterization and biology.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan;13(1):e1665. doi: 10.1002/wnan.1665. Epub 2020 Aug 23.
4
2D Nanomaterials for Cancer Theranostic Applications.
Adv Mater. 2020 Apr;32(13):e1902333. doi: 10.1002/adma.201902333. Epub 2019 Jul 28.
5
Theranostic nanomedicine.
Acc Chem Res. 2011 Oct 18;44(10):1029-38. doi: 10.1021/ar200019c. Epub 2011 May 5.
6
Nanomedicines: addressing the scientific and regulatory gap.
Ann N Y Acad Sci. 2014 Apr;1313:35-56. doi: 10.1111/nyas.12403. Epub 2014 Mar 27.
7
Nanotechnology and nanomedicine: going small means aiming big.
Curr Pharm Des. 2010 Jun;16(16):1882-92. doi: 10.2174/138161210791208992.
8
Nanomedicines for Renal Management: From Imaging to Treatment.
Acc Chem Res. 2020 Sep 15;53(9):1869-1880. doi: 10.1021/acs.accounts.0c00323. Epub 2020 Aug 12.
9
Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
Adv Mater. 2020 Apr;32(13):e1901989. doi: 10.1002/adma.201901989. Epub 2019 Jul 9.
10
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
Molecules. 2024 Apr 30;29(9):2073. doi: 10.3390/molecules29092073.

引用本文的文献

1
Nanomaterial-based encapsulation of biochemicals for targeted sepsis therapy.
Mater Today Bio. 2025 Jul 4;33:102054. doi: 10.1016/j.mtbio.2025.102054. eCollection 2025 Aug.
3
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation.
Clin Exp Med. 2025 May 17;25(1):166. doi: 10.1007/s10238-025-01686-z.
4
Clinical Applications of Targeted Nanomaterials.
Pharmaceutics. 2025 Mar 17;17(3):379. doi: 10.3390/pharmaceutics17030379.
6
Unravelling the complexity of CARPA: a review of emerging advancements in therapeutic strategies.
Arch Dermatol Res. 2025 Feb 19;317(1):439. doi: 10.1007/s00403-025-03971-z.
8
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges.
Mol Cancer. 2025 Jan 18;24(1):26. doi: 10.1186/s12943-024-02214-5.
9
Phytosomes Loaded with Mastoparan-M Represent a Novel Strategy for Breast Cancer Treatment.
Int J Nanomedicine. 2025 Jan 9;20:109-124. doi: 10.2147/IJN.S481871. eCollection 2025.
10
The Application of Nanomaterials in the Treatment of Pancreatic-Related Diseases.
Int J Mol Sci. 2024 Dec 7;25(23):13158. doi: 10.3390/ijms252313158.

本文引用的文献

1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
2
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Quant Imaging Med Surg. 2011 Dec;1(1):35-40. doi: 10.3978/j.issn.2223-4292.2011.08.03.
3
Nanoparticle-assisted combination therapies for effective cancer treatment.
Ther Deliv. 2010 Aug;1(2):323-34. doi: 10.4155/tde.10.13.
4
Nanotechnology in medicine: from inception to market domination.
J Drug Deliv. 2012;2012:389485. doi: 10.1155/2012/389485. Epub 2012 Mar 7.
6
Doxil®--the first FDA-approved nano-drug: lessons learned.
J Control Release. 2012 Jun 10;160(2):117-34. doi: 10.1016/j.jconrel.2012.03.020. Epub 2012 Mar 29.
7
Tumor heterogeneity and personalized medicine.
N Engl J Med. 2012 Mar 8;366(10):956-7. doi: 10.1056/NEJMe1200656.
8
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
N Engl J Med. 2012 Mar 8;366(10):883-892. doi: 10.1056/NEJMoa1113205.
9
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.
Chem Soc Rev. 2012 Apr 7;41(7):2971-3010. doi: 10.1039/c2cs15344k. Epub 2012 Mar 5.
10
Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes.
Biomaterials. 2012 May;33(13):3578-85. doi: 10.1016/j.biomaterials.2012.01.042. Epub 2012 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验